Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeutics
One of the most pressing challenges associated with SARS-CoV-2 treatment is the emergence of new variants that may be more transmissible, cause more severe disease, or be resistant to current treatments and vaccines. The emergence of SARS-CoV-2 has led to a global pandemic, resulting in millions of...
Main Authors: | Benjamin Ayodipupo Babalola, Oluwamayowa Samuel Akinsuyi, Elizabeth Oreoluwa Folajimi, Folakemi Olujimi, Ahmed Adebisi Otunba, Bruno Chikere, Ibitayo Ajayi Adewumagun, Tosin Emmanuel Adetobi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223008909 |
Similar Items
-
DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning
by: Volodymyr V. Oberemok, et al.
Published: (2023-01-01) -
GOLGA8 increases bulk antisense oligonucleotide uptake and activity in mammalian cells
by: Moira A. McMahon, et al.
Published: (2023-06-01) -
Reduction of Tumor Growth with RNA-Targeting Treatment of the NAB2–STAT6 Fusion Transcript in Solitary Fibrous Tumor Models
by: Yi Li, et al.
Published: (2023-06-01) -
Oligonucleotide-Based Approaches to Inhibit Dengue Virus Replication
by: Kingshuk Panda, et al.
Published: (2021-02-01) -
Progress in gene therapy mechanism of amyotrophic lateral sclerosis
by: LI Xiaoguang, YANG Lu, LIU Xudong, JIA Xinmiao, YANG Xinzhuang, CUI Liying
Published: (2023-04-01)